Infectious Diseases Related Content

While long COVID is slowly becoming more understood, ordinary COVID-19 patients are experiencing lasting effects - scientists discovered that 76% of people have atleast one recurring symptom, six months after the original illness.

Two divisions of Active Care Group – Christchurch Group and Remeo – discuss the importance of  infection prevention and control in the healthcare sector in light of COVID-19.

As of midnight tonight (20 December), London and the South East will enter strict Tier 4 restrictions - which includes no household mixing over Christmas, and no commuting to work.

Here, we learn about a British company launching a fast-acting antimicrobial coating that destroys coronavirus.

Kate Edwards, Director of LumiBio, highlights what we need to know about COVID-19 infection, prevention and control (IPC)

SureWash, a CPD certified hand hygiene training company has been helping healthcare facilities globally with the fight against COVID-19. Founder and CTO, Dr Gerard Lacey tells us about their technology and what comes next for the company.

Phillip P. Chan, MD, PhD, Chief Executive Officer of CytoSorbents Corporation (NASDAQ: CTSO), discusses the use of CytoSorb, a broad-spectrum blood purification technology to treat cytokine storm and hyperinflammation in critically ill COVID-19 patients.

Here, we discover that FebriDx® rapid point of care triage can help prevent the spread of infection and improve patient streaming.

Ann G. Matthysse, Professor of Biology from The University of North Carolina at Chapel Hill, shares her expertise on the transmission of Diarrheagenic E. coli by plants.

Used in medical settings for over 20 years, Sterilair is now being used in a wide range of close-contact environments to maintain healthy air quality.

Dr Jeremy Aroles explores the implications of COVID-19 technologies, and proposes three ways to ensure that these powers can't be abused by the Government.

While diabetes has been declared as a signifier for infection complications, researchers now say that data suggests it is three times as likely these individuals have severe COVID or are hospitalised.

Dr Sylvie Briand, Director, Global Infectious Hazards Preparedness Department at the World Health Organization, explains how COVID-19 is accompanied by fighting an infodemic.

Andrea Ammon, Director at the European Centre for Disease Prevention and Control, takes us on a journey from COVID-19 to the future of public health surveillance.

Anti Viral UVC explores how ultraviolet light works and how UVC energy is an effective and environmentally friendly way to eradicate dangerous microorganisms in any environment.

When it comes to HIV risks for women, researchers found that natural disasters force vulnerable women to take any chance to secure resources - whether through transactional sex or engagement in early marriage.

When it comes to COVID-19 testing labs, size isn’t everything, according to Alan Thornhill, UK Country Manager at Igenomix and Honorary Professor of Reproductive Genetics at the University of Kent, who spoke to Natalie Broome (MSc student, Kent).

The clinical trials are over for the Moderna vaccine - the company announced their drug was 94.1% effective and then filed for Emergency Use.

SureWash, a hand hygiene training company, has developed a new way of combining training and monitoring of hand washing.

Today (20 November) Pfizer and BioNTech are sending their drug for approval to the FDA, meaning that the most vulnerable Americans could get the vaccine in December.